Searched for
INDIA DRUG APPROVAL
Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killerIndia's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disea...- PM Modi pushes to cut imports to shield India from shocksIndia is likely preparing a major import substitution drive as geopolitical tensions and supply chain risks push the government to reduce d...
- Fatty liver new treatment found: Study discovers a medicine that reverses severe fatty liver by just repairing the gutA new experimental drug shows promise for severe fatty liver disease. This compound targets the gut, not the liver directly. It repairs a d...
- Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetesSouth Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...
- OneSource Specialty Pharma partners with Formycon AG to manufacture biosimilarsOneSource Specialty Pharma has announced a manufacturing partnership for biosimilars with Formycon AG. This collaboration will see OneSourc...
- FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drugThe US FDA approved an at-home starting dose for Eisai and Biogen's Alzheimer's drug. This new subcutaneous formulation allows patients to ...
- India seeks to quash Adani airport's nicotine pouch court challenge citing illegality, health riskIndia's government argues Adani Group's airport sale of nicotine pouches violates drug laws. The government asserts these sales pose a seri...
- Pharma body renews push for data protectionLeading pharmaceutical companies seek Regulatory Data Protection to boost research investments. Public health groups and local makers oppos...
- India-UK FTA: Pharma industry flags regulatory priorities ahead of July 15 rolloutIndustry stakeholders expect stronger trade, investment, and research partnerships but say implementation clarity will determine the pact’s...
- 600 dead in Democratic Republic of Congo Ebola outbreakThe Ebola outbreak in the Democratic Republic of Congo has now claimed 600 lives, figures published by the World Health Organization showed...
- Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increaseNovo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to ...
- Red Bull, Sting, etc. not recognised as 'energy drinks', says food regulator FSSAI as it issues notices over misleading claimsIndia's food regulator, FSSAI, has issued notices to several beverage brands for misbranding and misleading claims about their "energy drin...
- We are ready and confident: India on revamped Olympic host selection process for 2036India is actively pursuing its bid to host the 2036 Olympic Games in Ahmedabad, engaging with the IOC through various channels under a reva...
- Govt brings stem cell, gene therapies under central licensing frameworkIndia's drug regulations have been updated to include advanced treatments like cell, stem cell, gene therapies, and xenografts under centra...
- Shantha Biologics to make injectable drug cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...
- CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
Load More
